| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $208K | +37.7% | -74.0% |
| Cost of Revenue | $115K | +22.3% | -45.2% |
| Gross Profit | $93K | +63.2% | -84.2% |
| R&D Expense | $1.3M | +2.1% | +58.8% |
| SG&A Expense | $2.1M | +60.5% | +162.1% |
| Operating Income | -$3.4M | -25.9% | +47.6% |
| Pre-tax Income | -$3.5M |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $6.3M | +44.7% | +29.8% |
| Accounts Receivable | $120K | +23.7% | -64.7% |
| Inventory | $447K | +25.9% | -3.5% |
| Current Assets | $7.4M | +33.3% | +16.8% |
| Total Assets | $11.4M | +23.6% | +0.5% |
| Current Liabilities |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$6.2M | — | — |
| Capital Expenditures | $143K | — | — |
| Investing Cash Flow | $955K | — | — |
| Financing Cash Flow | $7.9M | — | — |
| Free Cash Flow | -$6.4M | — | — |
| -52.7% |
| +43.3% |
| Net Income | -$3.5M | -52.7% | +43.3% |
| EPS (Basic) | -$3.46 | -280.2% | +50.3% |
| EPS (Diluted) | -$3.46 | -280.2% | +50.3% |
| $4.3M |
| +101.4% |
| +109.0% |
| Total Liabilities | $7.3M | +40.1% | +27.5% |
| Stockholders' Equity | $4.1M | +2.0% | -27.1% |